Cargando…

Evaluating cardiac hypoxia in hibernating myocardium: Comparison of (99m)Tc-MIBI/(18)F-fluorodeoxyglucose and (18)F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium

The aim of this prospective study was to explore the feasibility of (18)F-fluoromisonidazole ((18)F-FMISO) cardiac positron emission tomography/computed tomography (PET/CT) in the detection of cardiac hypoxia in patients of ischemic heart disease (IHD) and to compare the uptake pattern with that of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagtap, Rajlaxmi, Asopa, Ramesh V., Basu, Sandip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357711/
https://www.ncbi.nlm.nih.gov/pubmed/30774543
http://dx.doi.org/10.4103/wjnm.WJNM_16_18
Descripción
Sumario:The aim of this prospective study was to explore the feasibility of (18)F-fluoromisonidazole ((18)F-FMISO) cardiac positron emission tomography/computed tomography (PET/CT) in the detection of cardiac hypoxia in patients of ischemic heart disease (IHD) and to compare the uptake pattern with that of (99m)Tc-MIBI and (18)F-fluorodeoxyglucose ((18)F-FDG). Twenty-six patients suffering from IHD were evaluated in this study. The patients initially underwent (99m)Tc-MIBI rest/stress myocardial perfusion imaging and (18)F-FDG cardiac PET/CT as a part of their routine cardiac imaging. Patients with hibernating myocardium on these scans further underwent (18)F-FMISO Cardiac PET/CT. Controls were also considered in the form of patients with scarred and normal myocardium. On visual assessment, increased (18)F-FMISO uptake was noted in the hibernating myocardium compared to scarred or normal myocardium. On semiquantification analysis, there was overlap in the uptake values with a range of maximum standardized uptake value (SUV(max)) in hibernating, scarred, and normal myocardium being 0.8–2.2 g/dl, 0.7–1.8 g/dl, and 0.7–1.6 g/dl, respectively. On individual patient-specific comparison in subjects harboring both hibernating and scarred myocardium, it was observed that SUV(max) of (18)F-FMISO in hibernating myocardium was highest, followed by scarred myocardium and normal myocardium, respectively. The ratio of (18)F-FMISO SUV(max) of hibernating to the normal myocardium in these subjects was always more than 1, and never less than the ratio of SUV(max) of scarred to normal myocardium. Thus, in this mixed population study, it was observed that on an individual patient basis, hypoxic myocardium consistently showed higher (18)F-FMISO uptake than surrounding scarred and normal myocardium. The ratio of (18)F-FMISO SUV(max) of hibernating to normal myocardium was higher than the ratio of scarred to the normal myocardium in all patients. On overall basis, however, there was considerable overlap in the SUV values among hibernating, scarred, and normal myocardium resulting in difficulty in differentiation of these entities with FMISO cardiac PET. (18)F-FDG cardiac PET/CT remains the standard and superior method to determine hibernating myocardium in patients of IHD due to its superior contrast. The limitation of FMISO is poor signal to noise ratio because of high background uptake from the blood pool. Cardiac PET/CT with superior hypoxia tracers needs to be further examined for imaging cardiac hypoxia.